XML 38 R56.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity (Employee and Director Stock Options, Restricted Stock and ESPP) (Details 2) (USD $)
12 Months Ended
Dec. 29, 2012
population
Dec. 31, 2011
Jan. 01, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of employee populations for fair value assumptions 2    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Total unrecognized compensation cost related to unvested employee and director stock options $ 10,100,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Beginning balance 9,287,000    
Granted 3,237,000    
Exercised (1,342,000)    
Forfeited or expired (1,643,000)    
Ending balance 9,539,000 9,287,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Beginning balance $ 4.22    
Granted $ 5.96    
Exercised $ 2.56    
Forfeited or expired $ 5.95    
Ending balance $ 4.74 $ 4.22  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]      
Vested and expected to vest at end of period, Shares 9,539,000    
Vested and expected to vest at end of period, Weighted average exercise price $ 4.74    
Vested and expected to vest at end of period, Weighted average remaining contractual term 4 years 6 months 11 days    
Vested and expected to vest at end of period, aggregate intrinsic value 4,462,000    
Exercisable at end of period, Shares 5,013,000    
Exercisable at end of period, Weighted average exercise price $ 4.20    
Exercisable at end of period, Weighted average remaining contractual term 3 years 5 months 16 days    
Exercisable at end of period, aggregate intrinsic value 3,517,000    
Total intrinsic value of options exercised 3,400,000 6,600,000 5,300,000
Total fair value of options and RSU's vested and expensed 7,400,000 6,000,000 4,200,000
Grant date weighted average fair values based on fair value assumptions, options $ 2.74 $ 2.92 $ 2.31
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Shares of common stock available for future purchases under ESPP 3,000,000    
Stock options
     
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected volatility, percent, minimum 58.10% 57.40% 55.10%
Expected volatility, percent, maximum 59.50% 61.90% 61.60%
Risk-free interest rate, percent, minimum 0.006% 0.003% 0.78%
Risk-free interest rate, percent, maximum 0.01% 0.02% 2.47%
Dividend yield 0.00% 0.00% 0.00%
Weighted average period for recognition 4 years 6 months    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Shares of common stock available for future grants 6,900,000    
Stock options | Minimum
     
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected term 4 years 1 month 2 days 4 years 0 months 18 days 4 years 0 months 22 days
Stock options | Maximum
     
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected term 4 years 5 months 19 days 4 years 4 months 13 days 4 years 5 months 5 days
ESPP
     
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected term 6 months 6 months 6 months
Dividend yield 0.00% 0.00% 0.00%
Weighted average expected volatility rate (percent) 50.00% 48.10% 52.30%
Weighted average risk-free interest rate (percent) 0.12% 0.14% 0.20%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]      
Grant date weighted average fair values based on fair assumptions, non-options $ 1.35 $ 1.80 $ 1.07
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Granted, Weighted average grant date fair value $ 1.35 $ 1.80 $ 1.07
Restricted Stock Units (RSUs)
     
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]      
Grant date weighted average fair values based on fair assumptions, non-options $ 5.99    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Balance at the beginning of period, Shares 1,077,000    
Granted, Shares 643,000    
Vested, Shares (514,000)    
Forfeited, Shares (127,000)    
Balance at the end of period, Shares 1,079,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]      
Balance at the beginning of period, Weighted average grant date fair value $ 6.12    
Granted, Weighted average grant date fair value $ 5.99    
Vested, Weighted average grant date fair value $ 5.93    
Forfeited, Weighted average grant date fair value $ 5.95    
Balance at the end of period, Weighted average grant date fair value $ 6.15    
Unrecognized compensation expense related to unvested RSU's $ 5,400,000